Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A FitzGerald

Showing results (21-30 of 310) with videos related to

Pageof 31
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989
Regulation of thromboxane receptor activation in human plateletsR Murray, G A FitzGerald
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Isoprostanes: potential markers of oxidant stress in atherothrombotic diseaseC Patrono, G A FitzGerald
The Journal of Biological Chemistry|April 12, 1996
Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2D Praticó, G A FitzGerald
Circulation Research|September 29, 2001
Smoking-induced vascular disease: a new twist on an old themeP McNamara, G A FitzGerald
The Journal of Clinical Investigation|June 8, 2001
COX in a crystal ball: current status and future promise of prostaglandin researchG A FitzGerald, P Loll
The New England Journal of Medicine|August 11, 2001
The coxibs, selective inhibitors of cyclooxygenase-2G A FitzGerald, C Patrono
The Journal of Clinical Investigation|July 4, 2001
Genetic and pharmacological analysis of prostanoid receptor functionS Narumiya, G A FitzGerald
The Journal of Clinical Investigation|June 8, 1999
Not a mouse stirring: deletion of the EP2 and love's labor's lostS Austin, G A FitzGerald
Circulation|June 1, 1995
Testosterone and thromboxane. Of muscles, mice, and menD Pratico, G A FitzGerald
Annals of Epidemiology|July 1, 1992
Antiplatelet and anticoagulant drugs in coronary vascular diseaseG A FitzGerald, E Shipp
Pageof 31

Showing results (21-30 of 310) with videos related to

Sort By:
Pageof 31
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989
Regulation of thromboxane receptor activation in human plateletsR Murray, G A FitzGerald
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Isoprostanes: potential markers of oxidant stress in atherothrombotic diseaseC Patrono, G A FitzGerald
The Journal of Biological Chemistry|April 12, 1996
Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2D Praticó, G A FitzGerald
Circulation Research|September 29, 2001
Smoking-induced vascular disease: a new twist on an old themeP McNamara, G A FitzGerald
The Journal of Clinical Investigation|June 8, 2001
COX in a crystal ball: current status and future promise of prostaglandin researchG A FitzGerald, P Loll
The New England Journal of Medicine|August 11, 2001
The coxibs, selective inhibitors of cyclooxygenase-2G A FitzGerald, C Patrono
The Journal of Clinical Investigation|July 4, 2001
Genetic and pharmacological analysis of prostanoid receptor functionS Narumiya, G A FitzGerald
The Journal of Clinical Investigation|June 8, 1999
Not a mouse stirring: deletion of the EP2 and love's labor's lostS Austin, G A FitzGerald
Circulation|June 1, 1995
Testosterone and thromboxane. Of muscles, mice, and menD Pratico, G A FitzGerald
Annals of Epidemiology|July 1, 1992
Antiplatelet and anticoagulant drugs in coronary vascular diseaseG A FitzGerald, E Shipp
Pageof 31